Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Kopran Limited, an integrated pharmaceutical company, engages in the development, manufacture and marketing of active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, syrups, dry powder, suspension, and injectables, as well as branded and generic formulations. It also provides drugs in the categories of macrolide, penicillin, quinolone, anti-protozoal, sulphonamides, respiratory, tetracycline, cardiovascular, anti-diabetic, urology, pain management and anti-inflammatory, gastrointestinal, erectile dysfunction, anthemintic, anti-allergic, central nervous system, anti-malarial, anti-thyroid, and carbapenems. In addition, the company offers drugs for anti-hypertensive, neuromodulator, anti-acne, anti-infective, antibiotic, anti-thrombotic, anti-diabetic, anti-asthamatic, antihyperlipidemic, anti-convulsants, anti-anxiety, pulmonary arterial hypertension, chronic heart failure, neuropathic pain, and erosive esophagitis. Kopran Limited was incorporated in 1958 and is based in Mumbai, India.
Key Metrics
as of Sep 2026
Market Cap 1,124 Cr
P/E 45.00
Div Yield 1.29 %
Book Value βΉ110.00
52w High βΉ243.00
52w Low βΉ107.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
153.99
234.02
194.28
117.91
135.22
172.36
166.24
151.56
139.44
186.08
158.92
152.59
117.00
Expenses
138.18
201.08
176.52
123.19
121.09
155.27
146.39
136.83
121.28
164.39
135.34
129.76
110.69
Operating Profit
15.81
32.94
17.76
-5.28
14.13
17.09
19.85
14.73
18.16
21.69
23.58
22.83
6.31
OPM %
10.27
14.08
9.14
-4.48
10.45
9.92
11.94
9.72
13.02
11.66
14.84
14.96
5.39
Other Income
2.05
0.09
0.07
0.03
2.56
3.26
0.17
1.00
2.63
9.67
2.43
0.13
2.39
Depreciation
5.77
4.52
4.42
4.28
4.26
3.87
4.00
3.85
3.87
3.59
3.27
2.77
3.26
Interest
3.28
3.17
2.67
2.09
2.54
2.77
2.16
2.23
2.18
2.59
2.24
1.94
1.83
Profit before tax
8.81
25.34
10.74
-11.62
9.89
13.71
13.86
9.65
14.74
25.18
20.50
18.25
3.61
Tax %
23.84
25.57
13.04
-14.63
24.67
29.39
24.96
23.42
24.69
26.01
23.02
24.55
22.99
Net Profit
6.70
18.87
9.34
-9.92
7.45
9.68
10.40
7.38
11.10
18.62
15.79
13.77
2.77
EPS in Rs
1.39
3.91
1.94
-2.06
1.54
2.01
2.16
1.53
2.30
3.86
3.28
2.86
0.57
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
681.00 630.00 615.00 551.00 478.00 492.00 360.00 358.00 313.00 310.00 296.00 326.00
Expenses
619.00 557.00 540.00 499.00 390.00 410.00 313.00 312.00 283.00 274.00 266.00 294.00
Operating Profit
62.00 73.00 74.00 52.00 87.00 82.00 47.00 46.00 31.00 36.00 30.00 31.00
OPM %
9.00 12.00 12.00 9.00 18.00 17.00 13.00 13.00 10.00 12.00 10.00 10.00
Other Income
0.00 4.00 15.00 3.00 11.00 18.00 0.00 3.00 9.00 11.00 1.00 -48.00
Interest
10.00 9.00 9.00 6.00 5.00 6.00 9.00 9.00 9.00 14.00 13.00 13.00
Depreciation
17.00 16.00 13.00 13.00 11.00 10.00 10.00 9.00 9.00 8.00 8.00 10.00
Profit before tax
34.00 52.00 68.00 36.00 82.00 83.00 28.00 32.00 23.00 25.00 11.00 -39.00
Tax %
25.00 26.00 25.00 24.00 25.00 26.00 26.00 24.00 10.00 20.00 0.00 0.00
Net Profit
26.00 39.00 51.00 27.00 61.00 62.00 21.00 24.00 20.00 20.00 11.00 -39.00
EPS in Rs
5.33 7.99 10.57 5.65 12.66 14.24 4.86 5.55 4.74 4.60 2.48 -9.52
Dividend Payout %
56.00 38.00 28.00 53.00 24.00 21.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
48.00 48.00 48.00 48.00 48.00 43.00 43.00 43.00 43.00 43.00 43.00 41.00
Reserves
482.00 470.00 443.00 391.00 378.00 202.00 146.00 125.00 101.00 81.00 57.00 49.00
Borrowings
153.00 148.00 99.00 75.00 75.00 66.00 88.00 97.00 89.00 95.00 80.00 86.00
Other Liabilities
225.00 178.00 153.00 135.00 110.00 128.00 92.00 85.00 82.00 78.00 84.00 99.00
Total Liabilities
908.00 844.00 743.00 650.00 611.00 439.00 370.00 351.00 315.00 298.00 264.00 275.00
Fixed Assets
346.00 208.00 182.00 165.00 151.00 112.00 111.00 113.00 104.00 104.00 101.00 102.00
CWIP
25.00 113.00 97.00 70.00 36.00 43.00 30.00 24.00 10.00 6.00 3.00 1.00
Investments
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other Assets
537.00 522.00 465.00 415.00 425.00 284.00 229.00 214.00 201.00 187.00 160.00 172.00
Total Assets
908.00 844.00 743.00 650.00 611.00 439.00 370.00 351.00 315.00 298.00 264.00 275.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Cash from Operating Activity
67.00 42.00 43.00 34.00 -33.00 60.00 31.00 25.00 26.00 16.00 29.00 46.00
Cash from Investing Activity
-65.00 -56.00 -44.00 -13.00 -84.00 -25.00 -13.00 -25.00 -11.00 -18.00 -9.00 -10.00
Cash from Financing Activity
-21.00 26.00 1.00 -20.00 123.00 -35.00 -18.00 -1.00 -15.00 2.00 -19.00 -37.00
Net Cash Flow
-19.00 11.00 1.00 2.00 5.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Free Cash Flow
0.00 -17.00 -13.00 -27.00 -76.00 43.00 17.00 -6.00 14.00 0.00 18.00 35.00
CFO/OP %
117.00 76.00 77.00 90.00 -17.00 93.00 82.00 63.00 94.00 47.00 95.00 147.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
141.00 125.00 126.00 108.00 97.00 89.00 94.00 88.00 75.00 86.00 70.00 91.00
Inventory Days
137.00 153.00 126.00 133.00 202.00 121.00 154.00 129.00 138.00 122.00 119.00 78.00
Days Payable
131.00 108.00 103.00 89.00 84.00 104.00 95.00 90.00 118.00 95.00 115.00 119.00
Cash Conversion Cycle
146.00 170.00 149.00 152.00 215.00 106.00 153.00 127.00 96.00 113.00 74.00 50.00
Working Capital Days
91.00 113.00 131.00 139.00 158.00 81.00 79.00 70.00 60.00 43.00 34.00 9.00
ROCE %
7.00 10.00 14.00 8.00 21.00 30.00 14.00 16.00 14.00 19.00 14.00 14.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
44.43
44.43
44.43
44.43
44.43
44.42
44.45
44.49
44.49
44.49
44.49
44.49
FIIs
0.51
0.57
0.36
0.60
0.76
1.11
0.86
1.31
0.68
0.84
0.48
0.39
DIIs
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.22
0.14
1.20
0.14
0.35
Public
55.06
55.01
55.21
54.99
54.81
54.45
54.68
53.98
54.68
53.47
54.88
54.78
No. of Shareholders
56,925
58,639
60,886
62,222
60,194
58,652
60,560
57,154
51,492
50,850
51,636
53,791
Corporate Actions
25 records
Back to all stocks